Shandong Buchang Pharmaceuticals Co Ltd (603858) — Capital Reinvestment Ratio
Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Capital Reinvestment Ratio of 0.09x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥280.95 Million) in capital expenditures (CN¥25.50 Million). See 603858 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Buchang Pharmaceuticals Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Shandong Buchang Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see Shandong Buchang Pharmaceuticals Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.21x | CN¥939.95 Million | CN¥197.00 Million | ▲ +6.3% |
| 2022 | 0.20x | CN¥2.76 Billion | CN¥543.17 Million | ▼ -40.0% |
| 2021 | 0.33x | CN¥1.32 Billion | CN¥433.53 Million | ▲ +19.9% |
| 2020 | 0.27x | CN¥1.96 Billion | CN¥536.44 Million | ▲ +8.4% |
| 2019 | 0.25x | CN¥2.62 Billion | CN¥662.11 Million | ▼ -60.5% |
| 2018 | 0.64x | CN¥2.05 Billion | CN¥1.31 Billion | ▼ -13.9% |
| 2017 | 0.74x | CN¥1.96 Billion | CN¥1.46 Billion | ▲ +82.6% |
| 2016 | 0.41x | CN¥1.67 Billion | CN¥677.87 Million | ▲ +79.2% |
| 2015 | 0.23x | CN¥2.12 Billion | CN¥480.78 Million | ▲ +97.0% |
| 2014 | 0.12x | CN¥1.78 Billion | CN¥204.88 Million | ▼ -74.9% |
| 2013 | 0.46x | CN¥1.11 Billion | CN¥510.85 Million | ▲ +13.9% |
| 2012 | 0.40x | CN¥1.35 Billion | CN¥543.34 Million | ▲ +64.9% |
| 2011 | 0.24x | CN¥1.55 Billion | CN¥378.91 Million | — |